Abstract LB-208: Hijacking the PI3K/mTor and KRas/MEK/ERK signaling pathways with a therapeutic assault results in robust antitumor activity in PI3K/KRas and KRas mutant tumors
Year: 2011
Type: conference-abstract
Source: Cancer Research
Authors: Loic Vincent1, Anne Thomas1, Jianguo Ma2, Anderson Clark2, Jamie Shaw2, Stéphane Guérif1, Coumaran Egile1, Joanne Lager1, Laurent Debussche1, Christoph Lengauer1, Carlos Garcia-Echeverria1, Janet A. Ogden2
Institutions: Sanofi (France), EMD Serono, Inc. (United States)
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2000648009
